Endothelial Dysfunction Clinical Trial
Official title:
The Mechanism of Ischemic Post Conditioning in Humans, Minimizing Reperfusion Injury.
Reperfusion Injury occurs by the sudden blood flow to the injured and ischemic myocardium
during restoration of blood flow either by Mechanical revascularization or thrombolysis. A
phenomenon known as Pre-conditioning has been identified to limit the the extent and
severity of reperfusion injury but it is very difficult to apply it in patient care setting
as timing of acute cardiac or neurologic ischemic event is difficult to reliably predict.
Postconditioning or ischemic postconditioning is well known to attenuate the reperfusion
injury. There is enough data that shows the benefit of post conditioning in reducing the
reperfusion injury in animals. However postconditioning in humans has not been investigated.
We hypothesize that Post conditioning will attenuate the reperfusion injury and will be
comparable to the effect of preconditioning in humans.
Myocardial ischemia is one on the leading causes of mortality and morbidity in the United
States. The initial injury to the myocardium is due to a state of imbalance when oxygen
demand exceeds supply. This is most pronounced in the cases of sudden total occlusion of a
coronary artery that results in myocardial injury and necrosis (AMI). The main stay of the
therapy in these cases is the restoration of the flow to the ischemic myocardium by means of
reperfusion therapy such as thrombolysis or mechanical revascularization. Interestingly,
there is data to suggest that sudden restoration of blood flow to the ischemic myocardium
may cause another form of myocardial injury ,known as reperfusion injury.
Although initially controversial, reperfusion injury is now recognized as a distinct entity.
This refers to the sudden and brisk reperfusion of ischemic myocardium that may induce
injury that was not originally present-paradoxically exaggerating the end result of an
ischemic event. Reperfusion injury may increase infarct size, decrease myocardial
contractile function and induce or exaggerate vascular endothelial dysfunction. The
pathophysiology is not well understood, but some of the effects of reperfusion injury have
been attributed to the generation of free oxygen radical and increased oxidative stress
possibly related to the abnormalities of the nitric oxide synthase (NOS) enzyme and its
byproducts. These cellular events lead to the endothelial dysfunction, a pivotal event in
the development of reperfusion injury.
A concept known as pre-conditioning has been identified as a phenomenon that limits the
extent and severity of reperfusion injury. Classically, preconditioning refers to the
occurrence whereby repeated brief episodes of ischemia preceding a prolonged period of
ischemia results in marked diminution of ischemic injury and injury occurring during
reperfusion. The mechanism of this ischemic tolerance was thought to be secondary to the
recruitment of collateral circulation, as it was noted to develop in patients undergoing
serial balloon inflations during angioplasty. The cellular mechanism involved in ischemic
preconditioning are not completely understood, but may be related to the attenuation of
reperfusion injury. These findings are also corroborated by Kharbanda's group in their
findings made after inducing forearm ischemia in 31 healthy volunteers. In an attempt to
test the effects of ischemic preconditioning on the attenuation of ischemia-reperfusion
injury as it pertains to endothelial function and circulating blood cell function, the
forearms of these volunteers were made ischemic for a 20 minutes period using a pneumatic
blood pressure cuff to 200 mmHg. This method was then compared to the use of ischemic
preconditioning prior to the prolonged 20 minutes ischemic episode. Ischemic preconditioning
was induced by inflating the pneumatic cuff to 200 mmhg for 5 minutes and then deflating the
cuff. This was repeated for a total of 3 times. Radial artery reactivity testing and blood
samples were collected from the antecubital vein at timed intervals after cuff deflation in
both methods. It was noted that ischemic -preconditioning prior to prolonged forearm
ischemia prevented both endothelial dysfunction and neutrophil activation.
Unfortunately, although pre-conditioning has been extensively studied and has shown to
reduce reperfusion injury in both animal and human models, it is difficult to practically
apply this in a patient-care setting. This is because the timing of acute cardiac or
neurologic ischemic events is difficult to reliably predict. Accordingly, this has generated
great interest in a theory known as post-conditioning. Post conditioning or ischemic
post-conditioning is a concept whereby short, repetitive ischemic episodes applied during
early reperfusion of ischemic myocardium will attenuate reperfusion injury. It appears that
both pre-conditioning and post-conditioning target the same pathophysiological mechanism, or
share effects on a final common pathway involved in the pathogenesis of reperfusion injury.
In a recent study, the effects of ischemic post-conditioning were compared to ischemic
preconditioning in the coronary circulation of an animal model. An open chest, left anterior
descending coronary artery occlusion model was used in 29 dots (10 controls, 9
preconditioning, and 10 post-conditioning). When compared to controls, both interventions
showed protective myocardial effects. The strategy of post-conditioning had comparable
results to ischemic preconditioning regarding reduction in infarct size.
Endothelial dysfunction is on of the signs of early atherosclerosis, and also a major
component of ischemia-reperfusion injury. Several factors affect endothelial function, but
the presence of reactive oxygen species in the vessel wall and the ability of endothelium to
generated nitric oxide (NO) seem to be the most important determinants of endothelial
function. Due to abnormalities in NOS, the generation of free oxygen radicals increases, and
the level of NO decreases during an ischemic episode. This leads to significant alterations
in the endothelial function. Under ischemic conditions, nitric oxide synthase produces
superoxide (.O2-) in excess of nitric oxide (NO). Superoxide can react with the surrounding
nitric oxide to produce a potent oxidizing agent, peroxynitrite (ONOO-). These oxygen
radicals are thought to contribute to the development of ischemia-reperfusion injury in
humans. NO has been shown to play a significant role in reducing reperfusion injury in
humans. The group from our institution demonstrated this where reperfusion injury in the
forearm of human subjects was attenuated by the administration of tetrahydrobiopterin (BH4),
a cofactor for NOS that leads to the production of NO (unpublished data, Baballiaros et
al.). The time course for oxidative marker expression, such as NO, after
ischemia-reperfusion injury is expected to occur as early as 2.5 to 5 minutes after
reperfusion. Several studies have examined the time course of NO, nitrosyl hemoglobin,
glutathione reduction-oxidation, and hydro peroxides. In a study conducted by Mochizuki et
al, describing an arterial flow mediated dilation model, NO attained a peak value with a
first-order time delay and the peak level NO concentration was linearly correlated with
perfusion rate in each vessel. It must be noted, however, that the peak and duration of the
levels are somewhat variable and depend on perfusion flow and the diameter of the vessel.
Endothelial function can be non-invasively evaluated using Brachial (or Radial) artery
reactivity testing (BART) as a measure of flow-mediated dilation (FMD). Since it's
beginnings in 1989, the study of FMD has now taken on an expanded role in the understanding
of endothelial physiology. FMD is an endothelial dependent process that reflects relaxation
of a conduit artery when exposed to shear stress. Increased flow, and thereby increased
shear stress, through the brachial artery occurs after post occlusive reactive hyperemia.
Several studies have suggested that the maximal increase in diameter occurs after
approximately 60 seconds after the release of the occlusive cuff or after 45-60 seconds
after peak reactive hyperemia blood flow. The increase in diameter at this time is prevented
by the NO synthase inhibitor, N-G monomethyl-L-arginine, indicating that it is an
endothelial dependent process mediated by NO. Other measures of vasodilator response include
time to maximum response, duration of the vasodilator response, and the area under the
dilation curve .An impairment of endothelial function, via FMD assessment by BART, has been
shown to correlate with risk factors for coronary artery disease (smoking, hyperlipidemia,
diabetes mellitus) and adverse cardiovascular events.
Currently, there is data that shows the benefit of post-conditioning in reducing reperfusion
injury in animal models only. However the use of post-conditioning in humans to reduce
reperfusion injury has not been well investigated.Given that endothelial dysfunction is a
significant component of reperfusion injury, we propose to examine the effects of
post-conditioning on a reperfusion injury by using BART. This study will act as a pilot by
which we can compare the results of Post-conditioning to preconditioning to reduce the
reperfusion injury with BART in a human reperfusion injury model. The clinical relevance of
this study is paramount. If it can be shown that post-conditioning attenuates reperfusion
injury in humans, as assessed by BART a larger scale trial to assess post-conditioning on
prevention of ischemia reperfusion injury in humans will be necessary. Furthermore, this
allows for a possible therapeutic application in the clinical setting, such as potentially
providing post-conditioning measures to patients undergoing percutaneous coronary
intervention for abruptly occluded coronary arteries. Attenuation of reperfusion injury may
further reduce the associated morbidity and mortality of acute coronary ischemic events.
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Completed |
NCT04156711 -
Remote Ischemic Preconditioning in Patients Undergoing Acute Minor Abdominal Surgery
|
N/A | |
Recruiting |
NCT06133634 -
Fisetin to Improve Vascular Function in Older Adults
|
Phase 1/Phase 2 | |
Completed |
NCT05872139 -
Role of Mitochondrial-derived Oxidative Stress to Promote Vascular Endothelial Dysfunction in Non-exercisers With Aging
|
N/A | |
Recruiting |
NCT04558450 -
Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)
|
N/A | |
Terminated |
NCT03325933 -
Resistance Training and Cardiometabolic Health
|
N/A | |
Not yet recruiting |
NCT05939934 -
Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal
|
N/A | |
Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
Recruiting |
NCT02334839 -
The Association Between Severity of Hypertensive Disorder During Pregnancy and Endothelial Dysfunction
|
N/A | |
Recruiting |
NCT02020044 -
Outcome After Descemet Membrane Endothelial Keratoplasty (DMEK) and Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
|
N/A | |
Completed |
NCT01691404 -
Study on the Effects of Epicatechin and Quercetin Supplementation on Vascular Function and Blood Pressure (FLAVO)
|
N/A | |
Completed |
NCT01775865 -
Targeting Inflammation to Treat Cardiovascular Aging
|
Phase 2 | |
Terminated |
NCT01412216 -
The Effects of Sedentarism on Vascular Function, Inflammation, and Insulin Resistance
|
Phase 2 | |
Completed |
NCT01319344 -
Effect of Eplerenone on Endothelial Function in Metabolic Syndrome
|
Phase 3 | |
Completed |
NCT00990730 -
Atherosclerosis in Rheumatoid Arthritis
|
N/A | |
Completed |
NCT00987974 -
Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury
|
Phase 4 | |
Completed |
NCT00848302 -
Endothelial Function in Human Arteries
|
Early Phase 1 | |
Completed |
NCT00532844 -
A Phase 2, Pharmacokinetic (PK) Study of 6R-BH4 Alone or 6R-BH4 With Vitamin C in Subjects With Endothelial Dysfunction
|
Phase 2 | |
Completed |
NCT00376246 -
Effect of Ezetimibe on Flow-mediated Brachial Artery Reactivity in Healthy Subjects
|
Phase 4 | |
Completed |
NCT00775099 -
Combustion Derived Air Pollution and Vascular Function
|
N/A |